The PI3K/AKT/mTOR and ERK1/2 MAPK pathways are crucial for modulating the malignant phenotypes of tumor cells, including cell survival (Li et al., 2019) and apoptosis (Lee et al., 2018). This evidence concerns the gene AKT1 and neoplasm.